Woodstock Corp’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,285
Closed -$1.46M 171
2023
Q2
$1.46M Hold
14,285
0.17% 86
2023
Q1
$1.3M Hold
14,285
0.17% 89
2022
Q4
$543K Sell
14,285
-400
-3% -$15.2K 0.07% 112
2022
Q3
$369K Buy
14,685
+1,212
+9% +$30.5K 0.05% 127
2022
Q2
$409K Hold
13,473
0.06% 127
2022
Q1
$441K Sell
13,473
-664
-5% -$21.7K 0.05% 133
2021
Q4
$373K Sell
14,137
-15,333
-52% -$405K 0.04% 152
2021
Q3
$2.97M Buy
29,470
+1,840
+7% +$185K 0.35% 67
2021
Q2
$3.91M Buy
27,630
+6,413
+30% +$908K 0.46% 62
2021
Q1
$2.12M Buy
21,217
+150
+0.7% +$15K 0.27% 72
2020
Q4
$2.6M Sell
21,067
-825
-4% -$102K 0.35% 67
2020
Q3
$2.13M Buy
21,892
+6,783
+45% +$661K 0.34% 61
2020
Q2
$2.36M Hold
15,109
0.4% 60
2020
Q1
$2.18M Hold
15,109
0.44% 59
2019
Q4
$3.09M Sell
15,109
-5,515
-27% -$1.13M 0.5% 57
2019
Q3
$1.66M Hold
20,624
0.29% 72
2019
Q2
$1.95M Hold
20,624
0.34% 69
2019
Q1
$1.76M Hold
20,624
0.32% 70
2018
Q4
$1.16M Hold
20,624
0.23% 81
2018
Q3
$1.69M Sell
20,624
-3,106
-13% -$254K 0.29% 79
2018
Q2
$830K Buy
23,730
+3,978
+20% +$139K 0.15% 100
2018
Q1
$405K Buy
19,752
+4,636
+31% +$95.1K 0.08% 127
2017
Q4
$428K Buy
+15,116
New +$428K 0.08% 123